"Arming" the chimeric oncolytic adenovirus enadenotucirev to deliver checkpoint inhibitors and other therapeutics directly to tumours

Journal for ImmunoTherapy of Cancer - Tập 2 - Trang 1-1 - 2014
Brian R Champion1, Prithvi Kodialbail1, Sam Illingworth1, Nalini Rasiah1, Dan Cochrane1, John Beadle1, Kerry Fisher1, Alice CN Brown1
1PsiOxus Therapeutics Ltd, Abingdon, United Kingdom

Tài liệu tham khảo

Kuhn I, Harden P, Bauzon M: Directed evolution generates a novel oncolytic virus for the treatment of colon cancer. PLoS ONE. 2008, 3: e2409-10.1371/journal.pone.0002409.